Literature DB >> 8252812

Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism.

A I Roberts1, S M O'Connell, L Biancone, R E Brolin, E C Ebert.   

Abstract

Human intestinal intraepithelial lymphocytes (IEL) demonstrate target cell-restricted spontaneous cytotoxic (SC) activity that is due to CD2+CD3+CD8+CD16-CD56- effector cells; they kill epithelial cell (EC) tumours (such as DLD-1 colon cancer cells), but not natural killer (NK)-sensitive K-562 cells. The present study shows that the measured levels of SC activities by IEL correlated with those of autologous lamina propria lymphocytes (LPL), but not with those of peripheral blood lymphocytes (PBL). Also, the susceptibilities of DLD-1 cell clones to lysis by IEL and PBL effector cells did not correlate, suggesting different mechanisms of lysis. Antibody blocking experiments showed that the main surface molecules involved in lysis depended on the effector cell type: alpha E beta 7 (HML-1) on IEL and CD16 on PBL. No antibody-dependent cell-mediated cytotoxicity (ADCC) was demonstrated by IEL, even after stimulation with interferon-gamma (IFN-gamma). Few IEL expressed Fc receptors for IgG. This study describes further differences between the SC activities of IEL and PBL.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252812      PMCID: PMC1534451          DOI: 10.1111/j.1365-2249.1993.tb08229.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Simple linear regression in medical research.

Authors:  K Godfrey
Journal:  N Engl J Med       Date:  1985-12-26       Impact factor: 91.245

3.  Absence of K cells in human gut mucosa.

Authors:  R Clancy; A Pucci
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

4.  Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities.

Authors:  R P MacDermott; G O Franklin; K M Jenkins; I J Kodner; G S Nash; I J Weinrieb
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

5.  Characterization of an immunosuppressive factor derived from colon cancer cells.

Authors:  E C Ebert; A I Roberts; S M O'Connell; F M Robertson; H Nagase
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

6.  Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200.

Authors:  S R Targan; W Newman
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

7.  T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.

Authors:  R E Schmidt; J P Caulfield; J Michon; A Hein; M M Kamada; R P MacDermott; R L Stevens; J Ritz
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

8.  Do the CD45RO+CD8+ intestinal intraepithelial T lymphocytes have the characteristics of memory cells?

Authors:  E C Ebert
Journal:  Cell Immunol       Date:  1993-04-01       Impact factor: 4.868

9.  Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties.

Authors:  M Chiba; W Bartnik; S G ReMine; W R Thayer; R G Shorter
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

10.  Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site.

Authors:  B M Vose
Journal:  Int J Cancer       Date:  1982-08-15       Impact factor: 7.396

View more
  18 in total

Review 1.  Alpha E beta 7.

Authors:  P J Kilshaw
Journal:  Mol Pathol       Date:  1999-08

2.  The number of intraepithelial T cells decreases from ascending colon to rectum.

Authors:  J A Kirby; M Bone; H Robertson; M Hudson; D E J Jones
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

3.  Integrin alpha1beta1 (VLA-1) mediates adhesion of activated intraepithelial lymphocytes to collagen.

Authors:  A I Roberts; R E Brolin; E C Ebert
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

4.  What is the role of human intestinal intraepithelial lymphocytes?

Authors:  L K Trejdosiewicz
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC).

Authors:  F A Arosa; C Irwin; L Mayer; M de Sousa; D N Posnett
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 6.  The light and dark sides of intestinal intraepithelial lymphocytes.

Authors:  Hilde Cheroutre; Florence Lambolez; Daniel Mucida
Journal:  Nat Rev Immunol       Date:  2011-06-17       Impact factor: 53.106

7.  T cell receptor repertoire in the peripheral blood and intestinal mucosa of coeliac patients.

Authors:  N Lahat; A Ben-Nun; L Cohen; A Kinarty; A Lerner
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

8.  Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas.

Authors:  J Cresswell; H Robertson; D E Neal; T R Griffiths; J A Kirby
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

9.  Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes.

Authors:  A I Roberts; R S Blumberg; A D Christ; R E Brolin; E C Ebert
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

10.  Ocular surface epithelium induces expression of human mucosal lymphocyte antigen (HML-1) on peripheral blood lymphocytes.

Authors:  J A P Gomes; H S Dua; L V Rizzo; M Nishi; A Joseph; L A Donoso
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.